semaglutide shortage november 2025 news Drug Safety: Recalls for Compounded Semaglutide, Generic Synthroid; Safety updates for Lamictal, Kineret, Miebo eye drops, Zoladex; Microneedling Injuries, more The Semaglutide Shortage Is Ending:

Unlike traditional oral solid dosage products, oral GLP-1s require a distinct set of capabilities spanning advanced formulation and delivery science, specialised oral manufacturing for biologics, robust scale-up and lifecycle management, and resilient, high-quality supply chains

Hopes also were high that the medications might help people at risk for Alzheimers, but so far, that research has not panned out

More recent work has identified a second research area

Semaglutide: Selective GLP-1 receptor agonist with balanced G protein and beta-arrestin signaling

DSIP, in contrast, appears to facilitate sleep initiation and depth via slow-wave promotion rather than wakefulness suppression